We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+21.26%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$3.77B
AUM Growth
+$720M
Cap. Flow
+$280M
Cap. Flow %
7.43%
Top 10 Hldgs %
22.38%
Holding
294
New
116
Increased
45
Reduced
52
Closed
77

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$115M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$93.9M
3
NXPI icon
NXP Semiconductors
NXPI
+$57.1M
4
LLY icon
Eli Lilly
LLY
+$51.1M
5
QRVO icon
Qorvo
QRVO
+$47.7M

Top Sells

Rank Stock Value
1
MCHP icon
Microchip Technology
MCHP
+$72.6M
2
BMY icon
Bristol-Myers Squibb
BMY
+$66.5M
3
AMZN icon
Amazon
AMZN
+$65.6M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$58.8M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$53.4M

Sector Composition

Rank Sector Weight
1 Healthcare 42.9%
2 Technology 32.83%
3 Communication Services 8.98%
4 Financials 3.92%
5 Consumer Discretionary 3.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNAM
176
DELISTED
Avidity Biosciences
RNAM
$3.27M 0.09%
128,000
-44,978
-26% -$1.31M
PG icon
177
Procter & Gamble
PG
$345B
$3.21M 0.09%
+23,039
New +$3.22M
ORTX
178
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$3.18M 0.08%
73,546
+56,855
+341% +$2.55M
CCV.U
179
DELISTED
Churchill Capital Corp V Units, each consisting of one share of Class A common stock, and one-fourth of one redeemable warrant
CCV.U
$3.15M 0.08%
+300,000
New +$3.14M
THC icon
180
Tenet Healthcare
THC
$20.4B
$3.11M 0.08%
+77,826
New +$2.51M
GH icon
181
Guardant Health
GH
$21.4B
$3.07M 0.08%
+23,843
New +$2.74M
RTPZ.U
182
DELISTED
Reinvent Technology Partners Z Units, each consisting of one Class A ordinary share and one-fifth o
RTPZ.U
$2.96M 0.08%
+260,000
New +$2.93M
PVLA
183
Palvella Therapeutics
PVLA
$2.18B
$2.88M 0.08%
14,400
-4,759
-25% -$990K
ACAD icon
184
Acadia Pharmaceuticals
ACAD
$4.65B
$2.72M 0.07%
50,913
-276,502
-84% -$13.7M
ACHC icon
185
Acadia Healthcare
ACHC
$2.95B
$2.68M 0.07%
+53,286
New +$2.12M
SNCE
186
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$2.67M 0.07%
+12,505
New +$2.6M
TBIO
187
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$2.67M 0.07%
+144,843
New +$2.59M
CMPS
188
Compass Pathways
CMPS
$1.59B
$2.35M 0.06%
49,411
-53,533
-52% -$2.28M
DIOD icon
189
Diodes
DIOD
$4.06B
$2.33M 0.06%
32,980
-215,221
-87% -$13.9M
LH icon
190
Labcorp
LH
$25.3B
$2.31M 0.06%
+13,195
New +$2.28M
CD
191
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
$2.3M 0.06%
95,966
+25,966
+37% +$425K
HAACU
192
DELISTED
Health Assurance Acquisition Corp. SAIL Securities
HAACU
$2.2M 0.06%
+200,000
New +$2.17M
RGNX icon
193
Regenxbio
RGNX
$659M
$2.19M 0.06%
48,329
-227,113
-82% -$7.94M
FHTX icon
194
Foghorn Therapeutics
FHTX
$285M
$2.09M 0.06%
+103,040
New +$1.97M
REPL icon
195
Replimune Group
REPL
$1B
$2.07M 0.05%
+54,254
New +$2.26M
DCPH
196
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.99M 0.05%
+34,797
New +$2.06M
NARI
197
DELISTED
Inari Medical, Inc. Common Stock
NARI
$1.89M 0.05%
+21,635
New +$1.53M
IPG
198
DELISTED
Interpublic Group of Companies
IPG
$1.76M 0.05%
+74,994
New +$1.57M
TGTX icon
199
TG Therapeutics
TGTX
$7.46B
$1.73M 0.05%
33,252
-166,623
-83% -$5.63M
SNDX icon
200
Syndax Pharmaceuticals
SNDX
$1.69B
$1.73M 0.05%
+77,699
New +$1.61M
6 7
8
9 10

Similar funds

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM

Woodline Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Woodline Partners held 294 positions worth $3.77B, up 24% from $3.05B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Woodline Partners deployed $280M of net new capital in Q4 2020, opening 116 new positions and adding to 45 existing holdings. Its largest new stake was Amgen: 500,520 shares worth $115M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 45% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $58.8M trimmed.

  • Woodline Partners's largest Q4 2020 buy was Amgen: 500,520 shares worth $115M.
  • Woodline Partners added most to Eli Lilly in Q4 2020, an estimated $51.1M increase.
  • Woodline Partners's biggest Q4 2020 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $58.8M.
  • Woodline Partners fully exited Microchip Technology in Q4 2020, selling an estimated $72.6M.
  • Woodline Partners's ten largest holdings make up 22% of its $3.77B portfolio in Q4 2020.
  • Woodline Partners opened 116 new positions and closed 77 in Q4 2020.
  • Woodline Partners's portfolio value rose 24% quarter-over-quarter to $3.77B.

Based on Woodline Partners's 13F filing for Q4 2020, filed 16 Feb 2021.